
Glipotec MP 1mg/500mg/15mg Tablet
Marketer
Jantec Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glipotec MP 1mg/500mg/15mg Tablet
Metformin/Pioglitazone/Sitagliptin (1mg/500mg/15mg) tablets are a triple-combination medication for managing blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It improves insulin effectiveness, consequently reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Take with food to minimize gastric distress. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the usual schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase hypoglycemia risk. Regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Glipotec MP 1mg/500mg/15mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Glipotec MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glipotec MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Glipotec MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Glipotec MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glipotec MP 1mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Glipotec MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with a meal.
How Glipotec MP 1mg/500mg/15mg Tablet works:
Glipotec MP 1mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—a triple-action antidiabetic regimen. These medications employ distinct mechanisms to optimize blood glucose management when single or dual-agent therapies prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipotec MP 1mg/500mg/15mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glipotec MP 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Glipotec MP 1mg/500mg/15mg tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glipotec MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glipotec MP 1mg/500mg/15mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glipotec MP 1mg/500mg/15mg Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glipotec MP 1mg/500mg/15mg Tablet :
Should you forget a dose of Glipotec MP 1mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glipotec MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
